Business
This week in psychedelic business news: MindMed's MDMA research pipeline to treat Autism Spectrum Disorder; Cybin EMBARKs; Awakn and MindCure...
This week in psychedelic business news: UK fast tracks DMT for major depressive disorder; Field Trip Health expands its clinical...
A NEW Psilocybin-Depression Study Was Just Released: The Results Are BREATHTAKING | GAME OVER?🚀🍄 Hello Psychedelic Investors! It’s an early...
In this episode, we're covering what is microdosing and its purported benefits. You will learn how to microdose magic mushrooms....
In this chat, he discusses some of the challenges involved in moving virtual events to an in-person conference (during a...
The PROBLEM With Psilocybin - How Is BRIGHT MINDS Fixing That? (DRUG/BMBIF) In the interview we discuss most of Bright...
This week in psychedelic business news: Cybin inhales; atai Life Sciences expands; DEA grants new psilocybin license; and FDA backs...
What's up psychedelic investors! We have been seeing a lot of red in the last few months. Companies like MindMed...
Our resident psychedelic investor explains why psychedelic stocks are plummeting, and why patience can pay off big time....
Silo Wellness CEO Douglas K. Gordon tells Psychedelic Spotlight that this is a "crucial" step toward "the mainstream acceptance of...